Eight tips for the implementation of the first licenced peanut allergy oral immunotherapy into clinical practice

BACKGROUND: Shared learnings from the early use of novel therapies can aid in their optimization. The recent introduction of peanut oral immunotherapy (peanut OIT; Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp]) for peanut allergy addresses a significant unmet need but also highlights th...

Descripción completa

Detalles Bibliográficos
Autores principales: Portnoy, Jay, Ciaccio, Christina E., Beausoleil, Janet, Du Toit, George, Fineman, Stanley, Tilles, Stephen A., Zhang, June, Lawrence, Claire, Yassine, Mohamed, Mustafa, S Shahzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088027/
https://www.ncbi.nlm.nih.gov/pubmed/35534909
http://dx.doi.org/10.1186/s13223-022-00671-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088027/
https://www.ncbi.nlm.nih.gov/pubmed/35534909
http://dx.doi.org/10.1186/s13223-022-00671-5

Ejemplares similares